Epigenetically acting drugs could support cancer immunotherapy

Epigenetically active drugs enable the cell to read parts oft he genome that were previously blocked and inaccessible. This leads to the formation of new mRNA transcripts and also new proteins, as scientists from the German Cancer Research Center and the University Hospital Tübingen have now described in research published in Nature Communications. These “therapy-induced epitopes” could help the immune system recognize cancer cells.

Leave A Comment

Your email address will not be published. Required fields are marked *